The purpose of this study is to evaluate the efficacy and safety of Genakumab Injection in patients with Gouty Arthritis (GA).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The change in the gout pain intensity in the target joint measured by VAS
Timeframe: 72 hours post-dose
Time to first new flare
Timeframe: 12 weeks